Fs I believe you asked me about KERX on another board .
My wife is a PA in dialysis and also runs a stage 4 CKD clinic . The Head of her dept is of the view that FGEN is the Co to follow and once their drug Roxadustat is approved ( assuming its approved ) the treatments for anemia will likely change .
Note
" Roxadustat produces an increase in Hb levels, decrease in hepcidin and ferritin levels , and increase in total iron binding capacity levels , suggesting an improvement in iron mobilization that contributes to increased RBC production "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.